Creatine for Cognition: What Human Studies Have Tested

Verdict: Moderate. Pooled trials show a small memory benefit, larger in older adults, but the biggest preregistered trial found smaller effects than the early studies, and no trial has tested brain fog.

Creatine has had an unusual few years for a supplement. It moved from the gym shelf to the nootropic shelf, picked up a meta-analysis or two, and acquired the kind of social media following that usually precedes disappointment. This site’s earlier creatine review rated it Moderate. Since then, several larger or newer human studies have appeared, including a preregistered trial designed to replicate one of the best-known early results.

Rather than repeat the verdict, this post lines up what the human studies have actually tested: who took part, how much creatine they took and for how long, what was measured, and what came out. The pattern is more useful than any single result.

A clean pale table with a small glass dish of unlabeled white powder and a measuring scoop beside three plain folders of different thicknesses

What brain fog actually is

First, the diagnostic pause. Brain fog is a symptom, not a diagnosis. Its common treatable causes include sleep deprivation, hypothyroidism, iron-deficiency anemia, vitamin B12 deficiency, depression, perimenopause and long COVID, and each has its own treatment. Creatine treats none of them. If your fog is persistent and has not been looked at, start with what causes brain fog and a GP appointment. One point specific to creatine: several of its more interesting results come from people kept awake overnight, and if short sleep is behind your fog, fixing the sleep does more than any supplement that softens its effects.

What creatine is

Creatine is a compound made in the body and found in meat and fish. In cells, including neurons, it acts as a short-term energy buffer, helping to regenerate ATP when demand spikes. Supplements raise creatine levels in muscle readily and in the brain more modestly; uptake into the brain runs through a dedicated transporter and is usually described as slow, which is one reason most trials ran for weeks [5]. The cognitive hypothesis follows from that: if the brain’s energy buffer is low, or demand is unusually high, more creatine might help. That is a mechanism, not evidence of effect, and the trials below are what matter.

Almost every trial used creatine monohydrate, the cheapest and best-studied form. Doses fall into two groups: around 5g a day for several weeks, or a loading dose of about 20g a day for a week or less.

What the evidence shows

Young adults and the vegetarian question

The result that put creatine on the cognitive map came from Rae and colleagues in 2003: 45 young vegetarian adults took 5g a day for six weeks in a crossover design and improved substantially on backward digit span, a working memory test, and on Raven’s Advanced Progressive Matrices, a reasoning test [1]. Benton and Donohoe then gave 121 young women 20g a day for five days and found memory improvements in vegetarians but not in omnivores [2]. The natural reading was that creatine helps most when dietary intake is low.

Verdict: ModerateWho was tested, at what dose, and what moved

Young adults

  • Rae: 45 vegetarians, 5g a day for 6 weeks, large gains
  • Sandkühler: 123 adults, 5g a day for 6 weeks, small effect, p = 0.064
  • Meta-analysis, ages 11 to 31: memory SMD 0.03
  • No extra benefit for vegetarians in the larger trial

Under sleep loss

  • 19 adults, 20g a day for 7 days, then 24 hours awake
  • 15 adults, single 0.35g per kg dose overnight
  • Less decline on reaction time, memory and speed tasks
  • Small trials; neither replaces sleep

Older and clinical groups

  • Meta-analysis, ages 66 to 76: memory SMD 0.88
  • Post-COVID fatigue: 12 patients, 4g a day for 6 months, self-rated symptoms improved
  • Alzheimer's pilot: 20 patients, 20g a day for 8 weeks, no placebo group
Doses are the study protocols, not recommendations. No trial has enrolled people with brain fog. Creatine does not treat thyroid disease, anemia, B12 deficiency or depression; people with kidney disease should ask a doctor first.

In 2023, Sandkühler and colleagues tested this directly in the largest trial to date [4]. It was preregistered, double-blind and crossover, with 123 adults, about half of them vegetarian, taking 5g a day for six weeks, and it used the same two main tests as Rae. The result was much smaller. Bayesian analysis supported a small benefit, but the effect on backward digit span only bordered on statistical significance (p = 0.064), the reasoning test showed no significant effect, and eight exploratory tests showed no sign of improvement. Vegetarians did not benefit more than omnivores. Side effects were reported about four times as often with creatine as with placebo (RR 4.25). The authors concluded that creatine might have a small beneficial effect and that larger studies are needed.

This is a familiar pattern: an early, small trial with a large effect, followed by a larger, more rigorous trial with a small one. The vegetarian story is not disproven, but it is no longer the clean finding it appeared to be.

Under sleep deprivation

Two small trials looked at creatine during sleep loss. McMorris and colleagues gave 19 adults either 20g a day of creatine or placebo for seven days, then kept them awake for 24 hours [3]. The creatine group showed less decline in several measures, including choice reaction time, balance and mood.

Gordji-Nejad and colleagues tried something different: a single large dose, 0.35g per kilogram of body weight, taken in the evening by 15 healthy young adults during a night of sleep deprivation, compared with placebo on another night [5]. Over the following hours, the creatine night brought better performance on memory and processing speed tasks, lower fatigue ratings and changes in brain energy markers on spectroscopy. The result challenges the assumption that creatine only works after weeks of use. It also comes from 15 people, in one lab, with a dose far above what most trials used.

Older adults

The clearest pooled signal concerns age. Prokopidis and colleagues’ meta-analysis of randomized trials in healthy people included 8 trials in its main analysis and found a small overall improvement in memory (SMD 0.29) [6]. In adults aged 66 to 76, the effect was larger (SMD 0.88); in people aged 11 to 31, it was close to zero (SMD 0.03). Dose, duration and sex did not change the result. The authors noted moderate risk of bias, high heterogeneity and too few trials to assess publication bias, so the size of the older-adult effect is uncertain even if its direction looks real.

A broader 2024 meta-analysis by Xu and colleagues pooled 16 trials with 492 participants, including three in clinical groups [7]. It found improvements in memory (SMD 0.31), attention time and processing speed time, with no significant effect on overall cognition or executive function. The authors rated the certainty of evidence as moderate for memory and low for everything else. The paper has since received a published correction and a commentary, which is worth knowing before treating its numbers as settled.

Clinical groups

Two small studies have moved creatine toward conditions where fog is a real complaint. Slankamenac and colleagues randomized 12 people with post-COVID fatigue syndrome to 4g a day of creatine or placebo for six months [8]. Creatine raised measured creatine in muscle and brain tissue, general fatigue fell at three months compared with baseline, and several self-rated symptoms, including difficulty concentrating, improved by six months. Cognition was not tested objectively, and 12 participants is too few for much confidence.

Smith and colleagues gave 20g a day for eight weeks to 20 people with Alzheimer’s disease in a single-arm pilot [9]. Nineteen kept to the regimen, brain creatine rose by 11%, and scores on several cognitive measures improved. Without a placebo group, practice effects and expectation cannot be ruled out; the study was designed to test feasibility, and it did that.

On safety, creatine monohydrate has a long record in exercise research, with no significant adverse effects in healthy adults in studies lasting up to five years [10]. People with kidney disease, and anyone taking regular medication, should talk to a doctor before using it.

What the trials measured, and what they did not

Across these studies, the outcomes were laboratory tests: digit span, reasoning matrices, word-pair recall, reaction time and composite scores from test batteries. They are reasonable measures of specific cognitive functions, and they are not the same as thinking clearly through a working day. Only the post-COVID trial asked people about concentration in daily life, and it did so with a symptom rating rather than a test. Most trials were also short, from a single night to a few weeks, so they describe what creatine does while it is being taken, not whether any change lasts.

The populations are narrower than the headlines suggest. Most participants were healthy young adults, and the trials with the largest effects tended to be among the smallest. Among the individual trials discussed here, only the Sandkühler trial enrolled more than 121 people. None of the trials enrolled people who described themselves as having brain fog, and none screened participants for its treatable causes. That matters for anyone reading these results from inside a foggy month: the evidence describes what creatine does to test scores in mostly healthy people, which is a different question from whether it will help you.

Verdict

Moderate. Pooled randomized trials show a small, real-looking improvement in memory, with the clearest benefit in older adults, and small trials suggest creatine can blunt some effects of sleep deprivation. Against that, the largest preregistered trial in young adults found a smaller effect than the early studies and did not confirm the vegetarian advantage, most trials are small, and the newest clinical results come from a 12-person trial and an uncontrolled pilot. No trial has tested creatine in people whose main complaint is brain fog.

For a rested, well-fed younger adult, the evidence points to an effect too small to notice. For older adults, the signal is more interesting but not yet secure. For brain fog, creatine remains a plausible idea with no direct test behind it.

What remains unknown

The biggest gap is the obvious one: no trial has enrolled people with brain fog and measured whether it improves. The post-COVID trial is a start, but it was tiny and relied on self-rated symptoms. It is unclear whether the older-adult memory benefit holds up in larger, preregistered trials. The right dose for cognition has never been established; most trials borrowed doses from exercise research, and the single-dose sleep deprivation result has not been replicated. Long-term cognitive effects, beyond about six months of use, are untested. And the gap between the early trials and the largest recent one suggests that small-study effects may have inflated the picture, which only more large, preregistered trials can settle.

If brain fog is new, persistent, or affecting daily life. See a doctor. Brain fog can be caused by conditions that are straightforward to treat once identified, including thyroid disorders, anemia, sleep apnea, and depression. A blood panel and a conversation with a GP is the first step, before any supplement.

Frequently asked questions

What doses of creatine have cognitive trials used?

Most used creatine monohydrate at around 5g a day for several weeks, or a loading dose of about 20g a day for 5 to 7 days. Across the trials in one meta-analysis, doses ranged from about 2.2g to 20g a day and durations from 5 days to 24 weeks. One sleep deprivation study used a single dose of 0.35g per kilogram of body weight. These are study protocols, not recommendations; anyone with kidney disease or taking regular medication should ask a doctor first.

Does creatine improve memory?

Modestly, on pooled evidence. A 2023 meta-analysis of 8 randomized trials in healthy people found a small overall improvement in memory (SMD 0.29). The effect was larger in adults aged 66 to 76 (SMD 0.88) and close to zero in people aged 11 to 31 (SMD 0.03). The authors noted moderate risk of bias and substantial heterogeneity.

Do vegetarians benefit more from creatine?

Early trials suggested so, but the largest test of the idea did not confirm it. A 2023 preregistered crossover trial of 123 adults, about half vegetarian, found no difference in benefit between vegetarians and omnivores.

Has creatine been tested for brain fog?

Not directly. One small randomized trial in 12 people with post-COVID fatigue syndrome found that 4g a day for 6 months improved several self-rated symptoms, including difficulty concentrating, but cognition was not measured with objective tests. No trial has enrolled people with brain fog as the main complaint.

Does creatine help when you are sleep deprived?

Two small trials suggest it may reduce the drop in performance. In one, 19 adults took 20g a day for 7 days before 24 hours awake; in another, 15 adults took a single large dose during a night of sleep deprivation and performed better on memory and processing speed tasks. Neither replaces sleep.

Sources and further reading

  1. Rae et al. -- Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial

    Proceedings of the Royal Society B, 2003, 270(1529):2147-2150. Crossover trial in 45 young vegetarian adults, 5g/day for 6 weeks. Significant improvements in backward digit span and Raven's Advanced Progressive Matrices.

  2. Benton and Donohoe -- The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores

    British Journal of Nutrition, 2011. Randomized trial in 121 young women, 20g/day for 5 days. Memory improved in vegetarians but not omnivores.

  3. McMorris et al. -- Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol

    Psychopharmacology, 2006. Double-blind trial in 19 adults, 20g/day for 7 days, then 24 hours of sleep deprivation. The creatine group showed less decline in random movement generation, choice reaction time, balance and mood.

  4. Sandkühler et al. -- The effects of creatine supplementation on cognitive performance: a randomised controlled study

    BMC Medicine, 2023, 21:440. Preregistered, double-blind crossover trial in 123 adults, about half vegetarian, 5g/day for 6 weeks. Bayesian evidence for a small benefit; backward digit span effect bordered significance (p = 0.064), Raven's matrices not significant; no benefit on 8 exploratory tests; no difference by diet; side effects reported more often with creatine (RR 4.25).

  5. Gordji-Nejad et al. -- Single dose creatine improves cognitive performance and induces changes in cerebral high energy phosphates during sleep deprivation

    Scientific Reports, 2024. Double-blind randomized crossover in 15 healthy adults aged 20-28 during 21 hours of sleep deprivation. A single 0.35 g/kg dose versus placebo improved memory and processing speed tasks and reduced fatigue ratings, with brain spectroscopy changes.

  6. Prokopidis et al. -- Effects of creatine supplementation on memory in healthy individuals: a systematic review and meta-analysis of randomized controlled trials

    Nutrition Reviews, 2023, 81(4):416-427. 10 RCTs reviewed, 8 meta-analyzed. Overall memory SMD 0.29 (95% CI 0.04-0.53); adults aged 66-76 SMD 0.88; ages 11-31 SMD 0.03. Doses about 2.2-20g/day, 5 days to 24 weeks; moderate risk of bias and high heterogeneity.

  7. Xu et al. -- The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis

    Frontiers in Nutrition, 2024, 11:1424972. 16 RCTs, 492 participants aged 20.8-76.4, including 3 trials in clinical groups. Improvements in memory (SMD 0.31), attention time and processing speed time; no significant effect on overall cognition or executive function. Moderate certainty for memory, low for other domains. A correction and a commentary have since been published.

  8. Slankamenac et al. -- Effects of six-month creatine supplementation on patient- and clinician-reported outcomes, and tissue creatine levels in patients with post-COVID-19 fatigue syndrome

    Food Science and Nutrition, 2023. Randomized, double-blind, placebo-controlled trial in 12 patients, 4g/day for 6 months. Brain and muscle creatine rose; general fatigue fell at 3 months versus baseline; several self-rated symptoms, including difficulty concentrating, improved at 6 months.

  9. Smith et al. -- Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition

    Alzheimer's and Dementia: Translational Research and Clinical Interventions, 2025. Single-arm pilot, 20 patients, 20g/day for 8 weeks. 19 met the compliance target; brain total creatine rose 11%; total and fluid cognition composites improved. No placebo group.

  10. Kreider et al. -- International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine

    Journal of the International Society of Sports Nutrition, 2017. Review of safety data from exercise research; no significant adverse effects in healthy adults in studies lasting up to 5 years.

Sources checked October 29, 2026. This is an editorial summary, not a systematic review or individual advice.

Get new articles by email

New articles from Fog Check, sent to your inbox. Unsubscribe at any time.

Related articles

Ginkgo Biloba for Brain Fog: What the Evidence Shows

An evidence audit of ginkgo biloba for brain fog and memory: the GEM trial of 3,069 older adults, a meta-analysis in healthy people, the Cochrane review, safety and interactions, and a verdict.

L-Theanine Without Caffeine for Focus: What the Evidence Shows

Does L-theanine help focus without caffeine? A 2026 meta-analysis of 31 randomized trials found a short-term benefit on a reaction-time measure of attention, with inconsistent anxiety results. Here is what it shows and what it does not.